Dermatology drug developer Azitra upsizes proposed IPO to $20M (AZTR)
Andrey Tolkachev Dermatology drug developer Azitra (AZTR) has barely upsized its proposed preliminary public providing to $20M. Azitra mentioned in a submitting that it was now trying to provide 2.4M ...